Press release
Neurostimulation Devices Market to Reach US$ 17.82 Billion by 2033, Fueled by AI-Integrated and Closed-Loop Technologies
According to DataM Intelligence, the global neurostimulation devices market size reached US$ 6.99 billion in 2024 from US$ 6.36 billion in 2023 and is expected to reach US$ 17.82 Billion by 2033, growing at a CAGR of 11.1% during the forecast period 2025-2033.The neurostimulation devices market encompasses implantable and external devices designed to modulate neural activity for therapeutic purposes, addressing conditions from chronic pain and movement disorders to epilepsy and depression. This market includes tools for spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and non-invasive brain and peripheral stimulators, serving hospitals, clinics, and research institutions.
π Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):- https://www.datamintelligence.com/download-sample/neurostimulation-devices-market?sindhuri
β Neurostimulation Devices Market Forces Driving Future Growth
The neurostimulation devices market is driven by rising technological advancements, such as closed-loop systems and high-frequency stimulation, along with the increasing prevalence of neurological diseases, an aging population, and demand for minimally invasive therapies. These innovations improve therapeutic outcomes, expand indications, and enhance patient experience, as seen in Medtronic's Percept PC DBS with BrainSense technology.
However, cybersecurity and data privacy concerns are hampering growth, with vulnerabilities in wireless systems potentially allowing unauthorized access and altering therapy. Compliance with regulations like HIPAA and GDPR adds complexity and cost, as highlighted by reports of 23 million breached healthcare records in 2023.
Opportunities include further advancements in miniaturization, rechargeable batteries, AI integration, and expansion into non-invasive home-use devices, which could lower barriers to adoption and open broader applications worldwide.
β Neurostimulation Devices Industry News:
FDA Approvals: In February 2025, Medtronic received FDA approval for BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier, enhancing personalized therapy for Parkinson's patients.
Cybersecurity Warnings: The FDA has issued communications on vulnerabilities in implantable devices that could impact therapy parameters or patient data.
Market Dominance: Spinal cord stimulation devices hold a 26.25% share in 2024, driven by innovations like high-frequency and burst stimulation from companies such as Nevro and Abbott.
Regional Leadership: North America maintains a 44.03% share in 2024, supported by advanced infrastructure and high adoption rates.
β Neurostimulation Devices Market: Industry Giants and Emerging Leaders:
β’ Medtronic
β’ Boston Scientific Corporation
β’ Abbott
β’ Aleva Neurotherapeutics
β’ NeuroPace, Inc.
β’ LivaNova PLC
β’ Nevro Corp
β’ Nalu Medical
β’ Curonix LLC
β’ Phagenesis Limited
Research Methodology
Our research methodology employs a dual approach, combining qualitative insights with rigorous quantitative analysis to provide comprehensive and reliable market intelligence. The process begins with thorough secondary research, drawing from trusted industry publications, proprietary databases, and credible market sources. This is further enhanced by focused primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
π Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/neurostimulation-devices-market
β Segment Covered in the Neurostimulation Devices Market:
By Device Type
Spinal Cord Stimulation Devices dominate with a 26.25% share in 2024, due to proven efficacy in chronic pain management and innovations like high-frequency stimulation. Deep Brain Stimulation Devices support conditions like Parkinson's with closed-loop systems. Vagus Nerve Stimulation Devices address epilepsy and depression. Sacral Nerve Stimulation Devices target urinary and bowel disorders. Non-Invasive Brain & Peripheral Stimulators expand access for home use. Others include emerging technologies.
By Application
Pain Management leads as a key use for chronic conditions. Epilepsy benefits from targeted stimulation. Parkinson's Disease & Movement Disorders see advancements in adaptive therapies. Depression & Psychiatric Indications grow with non-invasive options. Migraine & Cluster Headache applications are expanding. Sleep Disorders involve emerging neuromodulation. Others cover additional neurological indications.
By End-User
Hospitals are primary settings for implantation and procedures. Specialty/Neurology Clinics handle follow-up and adjustments. Ambulatory Surgical Centers support minimally invasive therapies. Rehabilitation Centers aid recovery. Academic and Research Institutes drive innovation. Others include home care and emerging facilities.
By Region
North America holds the largest share at 44.03% in 2024, driven by advanced infrastructure and reimbursement. Europe follows with strong adoption. Asia Pacific is projected for fastest growth due to healthcare modernization. Latin America, Middle East, and Africa show emerging potential.
β This Report Covers:
β Go-to-market Strategy.
β Neutral perspective on the market performance.
β Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
β Customized regional/country reports as per request and country level analysis.
β Potential & niche segments and regions exhibiting promising growth covered.
β Top-down and bottom-up approach for regional analysis
π Buy Now & Unlock 360Β° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=neurostimulation-devices-market
β Regional Analysis for Neurostimulation Devices Market:
β₯ North America (U.S., Canada, Mexico)
β₯ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
β₯ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
β₯ South America (Colombia, Brazil, Argentina, Rest of South America)
β₯ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
π Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
β Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
β Competitive Landscape
β Sustainability Impact Analysis
β KOL / Stakeholder Insights
β Unmet Needs & Positioning, Pricing & Market Access Snapshots
β Market Volatility & Emerging Risks Analysis
β Quarterly Industry Report Updated
β Live Market & Pricing Trends
β Import-Export Data Monitoring
β Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurostimulation Devices Market to Reach US$ 17.82 Billion by 2033, Fueled by AI-Integrated and Closed-Loop Technologies here
News-ID: 4171348 • Views: β¦
More Releases from DataM Intelligence 4Market Research LLP

Rare Disease Therapeutics Market to Reach US$ 495.27 Billion by 2033, Growing at β¦
According to DataM Intelligence, the global rare disease therapeutics market reached US$ 135.88 billion in 2023, with a rise of US$ 154.64 billion in 2024, and is expected to reach US$ 495.27 billion by 2033, growing at a CAGR of 13.8% from 2025 to 2033.
The Rare Disease Therapeutics Market refers to the sector focused on developing and distributing treatments for rare diseases, which affect a small percentage of theβ¦

Lymphedema Treatment Market is expected to reach US$ 2,029.90 million by 2033 | β¦
Global lymphedema market reached US$ 989.85 million in 2024 and is expected to reach US$ 2,029.90 million by 2033, growing at a CAGR of 8.8 % during the forecast period of 2025-2033.
The Lymphedema Market focuses on the diagnosis, treatment, and management of lymphedema, a chronic condition characterized by abnormal accumulation of lymphatic fluid, typically in the arms or legs, due to lymphatic system dysfunction. It often arises as a complicationβ¦

Colonoscopes Market to Reach US$ 5.05 Billion by 2033, Driven by Rising Colorect β¦
According to DataM Intelligence, thel Colonoscopes Market reached US$ 2.37 Billion in 2024 and is expected to reach US$ 5.05 Billion by 2033, growing at a CAGR of 8.8% from 2025 to 2033.
The Colonoscopes Market refers to the sector focused on devices used for visual examination of the colon to detect abnormalities like polyps or cancer. This market includes reusable and disposable colonoscopes, supporting screening, diagnostic, and therapeutic proceduresβ¦

Laser-Assisted Liposuction Market to Reach US$ 4.64 Billion by 2033 with 13.2% C β¦
The global laser-assisted liposuction market reached US$ 1,518.82 million in 2024 and is projected to reach US$ 4,642.60 million by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033.
Key Highlights from the Report
The global laser-assisted liposuction market is projected to grow from US$ 1,518.82 million in 2024 to US$ 4,642.60 million by 2033 at a CAGR of 13.2%.
North America dominates with a 44.8% market share, driven byβ¦
More Releases for Device
Medical Device Regulatory Affairs Market Medical Device Regulatory Affairs Marke β¦
"Medical Device Regulatory Affairs Market" in terms of revenue was estimated to be worth $ 6.7 billion in 2024 and is poised to reach $ 18.3 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1913
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global medical device regulatoryβ¦
Surge In Wireless Device Usage Boosts Wireless Audio Device Market Driving Marke β¦
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Wireless Audio Device Market Size By 2025?
In recent years, there has been remarkable growth in the wireless audio device market size. The market, which is projected to expand from $41.85 billion in 2024 to $52.37 billion in 2025, boasts a compound annual growth rate (CAGR) of 25.1%. Factors contributingβ¦
Anti-snoring Device Market - Quiet Nights, Restful Sleep: Anti-snoring Device In β¦
Newark, New Castle, USA: The "Anti-snoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Anti-snoring Device Market: https://www.growthplusreports.com/report/antisnoring-device-market/8931
This latest report researches the industry structure, sales, revenue,β¦
Global Watch Clock Measuring Device Market | Watch Clock Measuring Device Indust β¦
Watch, clock and measuring device market comprises of the sales of watch, clock, measuring device & related services to measure the time and physical quantity. Watch is portable timepiece, which is worn by people around the wrist, attached by a strap. Clock is a device used to measure and indicate time, using the pointers moving over a dial. Measuring device is an instrument used for measuring the various parameters inβ¦
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, β¦
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorderβ¦
Medical Device Technologies Market - The Evolution of Medical Device Technologie β¦
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario inβ¦